teaming up

Houston renewable energy company taps 2 industry partners for project

The facility will provide hundreds of jobs with an expected daily output of up to 3,000 barrels per stream that uses both renewable diesel and sustainable aviation fuel. Photo via Getty Images

A Houston company that's working on a major alternative energy facility in Texas has named two new partners on the project.

Santa Maria Renewable Resources has selected Topsoe as its technology provider, and executed license and engineering agreements, as well as partnered with an engineering firm for its East Texas facility.

The licenses encompass innovations like HydroflexTM and H2bridgeTM technologies. Topsoe’s HydroFlex process layout combined with the H2bridge lower carbon intensity of renewable fuels , and offers greenhouse gas emission savings. The process is part of a sustainable agriculture project currently in development by SMRR in East Texas.

The facility will provide 600 to 700 construction jobs and 300-plus permanent operating employment positions with an expected daily output of up to 3,000 barrels per stream that uses both renewable diesel and sustainable aviation fuel. The demand for RD and SAF grows,and the aviation industry aims to meet net zero carbon emissions by 2050.

SMRR has also partnered with Chemex Global to commence the front-end engineering design for the facility in East Texas.

“The collaboration with Topsoe and Chemex Global marks a significant company milestone, amplifying the potential of our project,” says Pat Sanchez, founder and CEO of SMRR, in a news release. “The incorporation of these licenses, complemented by tailored engineering insights from both organizations will seamlessly integrate into our ongoing front end engineering design. We’re pleased to collaborate with these industry experts ensuring the smooth progression on this project.”

SMRR is a vertically integrated renewable energy, and biobased production developer.

Trending News

A View From HETI

Cemvita has named a new leader in Brazil. Photo via cemvita.com

Houston industrial biotech company Cemvita has announced two strategic moves to advance its operations in Brazil.

The company, which utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals, acquired a complementary technology that expands its IP and execution of scale-up capacity, according to a news release. The acquisition will bring additional synthetic biology toolsets that Cemvita believes will assist with compressing and commercializing timelines.

The company also appointed Luciano Zamberlan as vice president of operations based in Brazil.

Zamberlan will lead operational execution, site readiness and early commissioning activities in Brazil. He brings more than 20 years of experience in biotechnology to the role. He recently served as director of engineering at Raízen, Brazil’s largest ethanol producer and the world’s largest producer of sugarcane ethanol. At Raízen, he coordinated the implementation of four greenfield plants and oversaw operational teams and process optimization for second-generation ethanol (E2G) and biogas.

“I am very pleased to join Cemvita, a company at the forefront of transforming waste into valuable, sustainable resources,” Zamberlan said in the release. “My expertise in scaling-up innovation, coupled with my experience in structuring and commissioning greenfield industrial operations, is perfectly aligned with Cemvita's mission and I'm eager to bring my energy and drive to accelerate Cemvita's industrial performance and contribute for a circular future.”

Cemvita expanded to Brazil in January to help capitalize on the country’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, enacted in 2024. The law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

“These steps enable us to augment Brazil’s longstanding bioindustrial ecosystem with next-generation capabilities, reducing early commercialization risk and expanding optionality for future product platforms,” Marcio Silva, CTO of Cemvita, said in the news release. “Together, they strengthen our ability to move from proof-of-concept to industrial reality.”

Trending News